Recently, Joel Litman has presented evidence that suggests Apple co-founder Steve Job’s last forecasts may be coming true before our own eyes.
If Litman is correct, it might be a fantastic opportunity for investors.
See our Steve Jobs’ Final Prophecy review to determine how the narrative ends.
What Is Steve Jobs’ Final Prediction?
Before he passed away, Steve Jobs made the last prediction that new technology would lead to advancements in vital sectors all across the world.
Some of the many sectors Steve Jobs anticipated being impacted by his ideas include healthcare, automobile, energy, and many more.
It’s not the standard tech that everyone is already betting on.
Now, Jobs may have been correct, and this transition might have had far-reaching consequences for the whole global economy.
So let’s take a deeper look at Steve Jobs to find out why his forecasts have carried so much weight before we go into the details of Jobs’ last prediction.
The SynBio Boom Steve Jobs Predicted Before He Died
Steve Jobs’ last predictions about how biology and technology might eventually merge seem to be coming true. In January 2020, researchers successfully sequenced the COVID-19 virus that caused the pandemic.
A preventative mRNA vaccine was developed because of the use of this computer model, which allowed researchers to identify and isolate the protein responsible for the disease’s spikes.
As far as Litman is concerned, this moment, which received surprisingly little coverage, heralded the start of a new era in which technological and biological fields worked together.
Litman calls this emerging field “SynBio,” and he thinks it has the potential to boost economies throughout the world significantly.
Synthetic Biology: The Justification
SynBio has the potential to be the most significant innovation in technology since the advent of the internet. As a result, SynBio, like the Internet before it, has the potential to revolutionize the economy and usher in a new period of unprecedented expansion.
The potential ramifications are huge. Self-healing rubber, a more compassionate kind of insulin produced from animals, and many more innovations are among the possibilities.
Although most of the industry is focused on 5G, electric vehicles, space exploration, AI, VR, etc., now may be a good time to invest in an under-the-radar technology.
We’re not saying that electric vehicles, artificial intelligence, and the other cutting-edge stuff making headlines today aren’t excellent; it just seems everyone already knows about it when investing. Getting in before the boom might result in significant rewards.
Additionally, given the decline of many well-known digital technology firms, it may be time to shift emphasis to businesses with genuine expansion prospects.
The potential of SynBio technology is limitless, and as Steve Jobs anticipated, it can bring about a global revolution. Moreover, early investors may reap enormous profits similar to the last IT boom.
SynBio: Opportunities Abound?
With the recent decline in the value of many technology companies’ shares, investors everywhere seek a fresh perspective. Indeed, SynBio may represent the next economic upswing.
Joel Litman has identified numerous publicly traded firms that have the potential to become industry leaders in the coming years.
As a part of Steve Jobs’ Final Prophecy package for Hidden Alpha, he has compiled his findings into a set of unique reports. Among them are five of his favorite SynBio stocks.
Who Is Steve Jobs?
Steve Jobs was a businessman with extraordinary insight and vision. Apple, the firm he started from nothing in his garage, is now worth more than a trillion dollars.
Steve Jobs became a visionary due to his extraordinary foresight into the future of technology and other industries.
He foresaw several historically significant innovations and financial trends, such as:
- The development of cloud-based services.
- An Individual Computer With a Graphical User Interface
- The evolution of portable computers
- The departure from command-line interfaces in favor of graphical user interfaces
- The voice-activated devices Alexa and Siri
- and other forms of electronic technology.
A cult formed around Jobs as he spent years in the limelight as an entrepreneur, and his ideas and strategies are still held in high regard today.
He was the driver behind countless technical breakthroughs that impressed customers and his rivals.
He led Apple, which delivered the first commercially viable computers with a graphical user interface.
Apple Lisa, a successful operating system, was created by Jobs’ team and was named after his daughter. Since then, Apple has established itself as not just a premier computer maker but also a technological pioneer in a wide range of fields.
Unfortunately, Job’s last prophecy would not come true for many years after he passed away. He foresaw that two of the most innovative sectors would merge to establish SynBio.
Jobs’ prognosis was largely ignored at the time.
However, his dream is becoming a reality today, and others are starting to take notice.
Joel Litman of Hidden Alpha is alerting his audience to this developing phenomenon via his Steve Jobs’ Final Prophecy talk.
What Is “Hidden Alpha”?
Joel Litman, altimetry and forensic accounting expert, publishes the monthly newsletter and research service Hidden Alpha.
Empire Financial Research, the makers of Empire Financial Daily, has a sibling business called Altimetry. Litman’s comprehensive financial research has allowed him to zero in on a group of large-cap companies that he believes are promising and cheap.
A comprehensive examination of Hidden Alpha is included in this bundle, although it is optional.
Members of Hidden Alpha get access to monthly stock picks, a comprehensive model portfolio, and many more advantages.
When you join up for the new offer, you’ll receive a 12-month membership to Hidden Alpha and all the perks of a premium member.
Hidden Alpha is a fantastic platform supported by a competent staff. A fantastic complement to Jobs’ Final Prophecy, this book will keep you occupied with monthly stock recommendations for a year.
Who Is Joel Litman?
Joel Litman is a forensic accounting specialist with decades of experience in the field. But, when it comes to the Hidden Alpha service, Litman is the man in charge.
Readers of Hidden Alpha may benefit much from Litman’s knowledge. Members have early access to his most recent discoveries, and he has a penchant for identifying attractive large-cap companies that the general market has neglected.
Litman has amassed an impressive record of success and is widely regarded as an expert in his area.
He is now the Chief Investment Strategist at Altimetry, the firm that publishes Hidden Alpha, and the Chief Executive Officer and President at Valens Research, the company that owns Altimetry.
In addition to being cited in publications for Barron’s and Institutional Investor, Litman has appeared on CNBC. In addition, the Harvard Business Review has included an article he wrote.
Having an impressive CV, Joel Litman is an expert in his field. You should pay attention to what he says about the market because he is generally correct and has seen a significant opportunity that might prove Jobs’ final prediction accurate.
How Much Does It Cost to Get Access To Hidden Alpha?
Steve Jobs’ Final Prophecy offer allows you to join at a steep discount.
Our readers may get a discount on the usually $199 annual membership cost to Hidden Alpha.
If you join up, you can get the whole shebang for just $49. That’s a savings of 75% off the list price!
Plus, you’ll still get Joel Litman’s five best stock picks for SynBio and all the other extra reports mentioned in this review.
Should You Invest in Steve Jobs’ Final Prophecy, Hidden Alpha?
Steve Jobs’ Final Prophecy package includes Hidden Alpha, a fantastic monthly research service, for a meager price. A whole year of Hidden Alpha and a wealth of extra data are yours to explore.
Best-in-class SynBio stocks and Joel Litman’s Perfect Portfolio might place you in a prime position to reap massive profits from this developing tech trend.
Market participants receive access to monthly newsletters, frequent updates, and a bonus market daily e-letter every trading day.
Taking advantage of the potential for SynBio to become a massive growth sector, as forecasted in Steve Jobs’s farewell address, is made easier with the tools in this bundle.